Re: Farmas USA
EXEL
Comentario de Morgan Stanley
More important than royalty, approval is a good sign for potential US approval in 2L HCC,model peak unadjusted sales of ~$500M Exelixis that is risk-adjusted using an 80% probability of success & provides greater confidence as Exelixis & Ipsen move ahead with frontline HCC
Vamos, que bien y tal eso de Europa, pero lo importante de verdad es aprobación en USA (pdufa 14 de enero)